VEA
VRDN icon

Virtus ETF Advisers’s Viridian Therapeutics VRDN Stock Holding History

Virtus ETF Advisers’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,952
Closed -$75.8K – 794
2024
Q4 		$75.8K Sell
3,952
-3,059
-44% -$66.5K 0.03% 346
2024
Q3 		$160K Buy
7,011
+127
+2% +$2.08K 0.07% 316
2024
Q2 		$89.6K Buy
6,884
+2,405
+54% +$33.3K 0.04% 361
2024
Q1 		$78.4K Sell
4,479
-308
-6% -$5.97K 0.04% 396
2023
Q4 		$104K Buy
4,787
+1,215
+34% +$19.2K 0.07% 342
2023
Q3 		$54.8K Sell
3,572
-358
-9% -$6.83K 0.03% 410
2023
Q2 		$93.5K Buy
3,930
+307
+8% +$7.87K 0.06% 410
2023
Q1 		$92.2K Sell
3,623
-1,394
-28% -$44.7K 0.05% 355
2022
Q4 		$147K Buy
+5,017
New +$116K 0.08% 352

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return